SWE to Detect Enthesitis in PsA: Relationship With SIRT2 Expression and Disease Activity
Condition(s) studied
Investigational drug(s) / intervention(s)
Musculoskeletal Ultrasound Device: Musculoskeletal Ultrasound assessment by LOGIQ P10 from General Electric (GE) Healthcare, each patient will be evaluated by grey scale, power doppler MSUS and Shear Wave Elastography (SWE)
Study summary
1. To assess the diagnostic utility of shear-wave elastography (SWE), gray-scale (GS) ultrasound, and Power Doppler (PD) in detecting Patellar and Achilles tendinopathy in psoriatic patients with and without arthritis.
2. Investigate the relation between SWE, GS ultrasound, and PD finding and SIRT2 expression levels.
3. Evaluate the association of the imaging findings and SIRT2 levels with psoriatic arthritis disease activity score.
Eligibility
Primary outcome measure(s)
- Assessment and comparting the diagnostic utility of shear-wave elastography (SWE) , Gray-scale (GS) ultrasound. and Power Doppler (PD) in detecting tendinopathy in psoriatic patients with and without arthritis. — At baseline (single study visit)
Musculoskeletal Ultrasound assessment by LOGIQ P10 from General Electric (GE) Healthcare, a division of General Electric Company
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Assiut University | Asyut | Egypt |
More Assiut University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07188688 on ClinicalTrials.gov ↗ ← All trials in Egypt